Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aclarion Inc
ACON
Healthcare
Biotechnology
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in...
the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACON)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on May 12, 2025 9:39am
RE:ACON....As much as I dislike this pile....
Meh....zero volume Me no position
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 12, 2025 8:42am
ACON....As much as I dislike this pile....
It's on my watch list I tend to think that this "thinner" will get pumped to raise $'s Currently at $7
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 09, 2025 7:00am
New Press Release - Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 02, 2025 6:00am
New Press Release - Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging servicesMICSC expands access to Nociscan beyond Beverly Hills now available in Santa MonicaBROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 31, 2025 7:00am
New Press Release - Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
Over $20M raised in Q1 with nearly $15M cash on handNo debt, no preferred equity, and no warrants with strike prices near the current marketNasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded with initial interim results expected in Q2...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 26, 2025 7:00am
New Press Release - Aclarion Announces Reverse Stock Split
BROOMFIELD, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back...
read article.
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 17, 2025 8:52am
Buy buddy buy because it's taking off this morning.
Otherwise you guys will be missing out on a massive amount of profits
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 17, 2025 7:54am
RE:ACON.... On watch
This is a set up.....me no position https://www.sec.gov/Archives/edgar/data/1635077/000168316825001566/aclarion_8k.htm
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 17, 2025 7:42am
ACON.... On watch
runner in PM trading
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 13, 2025 9:25am
New Press Release - Aclarion Provides Shareholder Update
BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 06, 2025 9:35am
New Press Release - Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
Lenox Hill Radiology (LHR) in New York and New Jersey Imaging Network (NJIN) to add Nociscan across multiple sites BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...
read article.
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 03, 2025 3:50pm
This stock is for swing trading only.
It was a big double in price per share for me today,and it was a bad day for the markets
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 03, 2025 7:51am
Using technical analysis for this stock.
There is a Big breakout pattern signalled by it this morning already
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 03, 2025 6:00am
New Press Release - Aclarion Announces First Commercial Agreement with Scripps Health
Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro areaNociscan leverages MR Spectroscopy (MRS) and Augmented Intelligence (AI) to Identify Sources of Chronic Low Back PainBROOMFIELD, Colo., March 03, 2025 (GLOBE...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 28, 2025 4:01pm
New Press Release - Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
Meeting adjourned to Wednesday, March 5, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW),ahealthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS...
read article.
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
How Web3 Will Fundamentally Reshape Finance